06:01 PM EDT, 04/19/2024 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on April 17, 2024, sold 34,079 shares in Immunovant ( IMVT ) for $990,269. Following the Form 4 filing with the SEC, Salzmann has control over a total of 1,052,879 shares of the company, with 1,052,879 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401324000075/xslF345X03/wk-form4_1713563823.xml